| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JA413063E |
| P698 | PubMed publication ID | 24456115 |
| P50 | author | Ben Feringa | Q3259614 |
| Willem A Velema | Q89848310 | ||
| Wiktor Szymanski | Q43743868 | ||
| P2860 | cites work | Photodynamic therapy in oncology | Q79215388 |
| Redox potential of azobenzene as an amino acid residue in peptides | Q79956898 | ||
| Antibiotics and antibiotic resistance genes in natural environments | Q81659169 | ||
| Regulation of human carbonic anhydrase I (hCAI) activity by using a photochromic inhibitor | Q81922128 | ||
| Fluorescence imaging of azobenzene photoswitching in vivo | Q83361594 | ||
| Light control of mitochondrial complex I activity by a photoresponsive inhibitor | Q83823324 | ||
| Exploring the pharmacology and action spectra of photochromic open-channel blockers | Q84583270 | ||
| Azobenzene photoswitches for Staudinger-Bertozzi ligation | Q85889066 | ||
| Optogenetics | Q86494033 | ||
| Next-generation optical technologies for illuminating genetically targeted brain circuits | Q24649053 | ||
| Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses | Q28205383 | ||
| Molecular mechanisms of nociception | Q28216291 | ||
| Rhodopsin-like protein from the purple membrane of Halobacterium halobium | Q28248225 | ||
| How many drug targets are there? | Q28276660 | ||
| Optical control of TRPV1 channels | Q28294957 | ||
| Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
| Neural substrates of awakening probed with optogenetic control of hypocretin neurons | Q29615343 | ||
| Azo-propofols: photochromic potentiators of GABA(A) receptors | Q30537959 | ||
| Biologically active molecules with a "light switch". | Q33249214 | ||
| Steroid hormone profiles of urban and tidal rivers using LC/MS/MS equipped with electrospray ionization and atmospheric pressure photoionization sources | Q33435653 | ||
| Photochromic blockers of voltage-gated potassium channels | Q33693599 | ||
| Photodynamic therapy in dermatology | Q33846093 | ||
| Role of activated oxygen species in photodynamic therapy | Q33977124 | ||
| Recent advances in the photochemical control of protein function | Q34079616 | ||
| Pharmacogenetics and adverse drug reactions | Q34088287 | ||
| Trends in risks associated with new drug development: success rates for investigational drugs | Q34096792 | ||
| Two possible roles of bacteriorhodopsin; a comparative study of strains of Halobacterium halobium differing in pigmentation | Q34140897 | ||
| Society's failure to protect a precious resource: antibiotics | Q34176981 | ||
| Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models | Q34276559 | ||
| Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. | Q34307105 | ||
| Molecular mechanisms of drug resistance | Q34382998 | ||
| The tandem Src homology 2 domain of the Syk kinase: a molecular device that adapts to interphosphotyrosine distances | Q34385835 | ||
| Caged compounds: photorelease technology for control of cellular chemistry and physiology | Q34392610 | ||
| The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. | Q34551456 | ||
| Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine | Q34574061 | ||
| From one-photon to two-photon probes: "caged" compounds, actuators, and photoswitches | Q34589382 | ||
| Investigation into the P3 binding domain of m-calpain using photoswitchable diazo- and triazene-dipeptide aldehydes: new anticataract agents | Q34627750 | ||
| The cancer biomarker problem | Q34767213 | ||
| A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma | Q34982679 | ||
| Augmented photoswitching modulates immune signaling | Q35001481 | ||
| Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients | Q35755733 | ||
| Tuning photochromic ion channel blockers | Q36105983 | ||
| Photoregulation of biological activity by photochromic reagents. 3. Photoregulation of bioelectricity by acetylcholine receptor inhibitors | Q36442564 | ||
| Photoregulation of biological activity by photocromic reagents. II. Inhibitors of acetylcholinesterase | Q36444222 | ||
| Azobenzene as conformational switch in model peptides. | Q36461769 | ||
| Photoremovable protecting groups in chemistry and biology: reaction mechanisms and efficacy. | Q36570458 | ||
| p-(4-Azipentyl)propofol: a potent photoreactive general anesthetic derivative of propofol | Q36634576 | ||
| Quantitative structure-pharmacokinetic/pharmacodynamic relationships | Q36648260 | ||
| Photochemical control of biological processes | Q36766448 | ||
| Redox characteristics of the eukaryotic cytosol | Q37014993 | ||
| Principles and applications of the photochemical control of cellular processes. | Q37158588 | ||
| Efficient drug lead discovery and optimization | Q37307959 | ||
| Metabolism of azo dyes: implication for detoxication and activation | Q37437836 | ||
| Two-photon absorption and the design of two-photon dyes | Q37445707 | ||
| Light activation as a method of regulating and studying gene expression | Q37456801 | ||
| Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy | Q37624003 | ||
| Oncologic photodynamic therapy photosensitizers: a clinical review | Q37761430 | ||
| Azobenzene photoswitches for biomolecules | Q37864104 | ||
| Photoisomerization in different classes of azobenzene | Q37947048 | ||
| Light-controlled synthetic gene circuits | Q38013440 | ||
| Advances in targeted therapeutic agents | Q38029122 | ||
| Light-controlled tools | Q38029303 | ||
| Multivalent ligand: design principle for targeted therapeutic delivery approach. | Q38056927 | ||
| Pathobiology of chemotherapy-induced hair loss | Q38078135 | ||
| Reversible photocontrol of biological systems by the incorporation of molecular photoswitches | Q38101354 | ||
| Design, synthesis, and inhibitory activity of potent, photoswitchable mast cell activation inhibitors | Q39160662 | ||
| The Glutathione Status of Cells | Q39293102 | ||
| Rapid optical control of nociception with an ion-channel photoswitch | Q39395066 | ||
| Synergistic drug combinations tend to improve therapeutically relevant selectivity | Q39828335 | ||
| Adverse drug reactions: definitions, diagnosis, and management | Q40739350 | ||
| The mechanism of microsomal azoreduction: predictions based on electronic aspects of structure-activity relationships | Q40923035 | ||
| Photoswitching of ortho-substituted azonium ions by red light in whole blood | Q41855023 | ||
| CLINICAL APPLICATIONS OF COOMASSIE BLUE. | Q42154034 | ||
| Switching between low and high affinity for the Syk tandem SH2 domain by irradiation of azobenzene containing ITAM peptidomimetics. | Q43284333 | ||
| Analysis of steroid hormones in a typical dairy waste disposal system | Q43358295 | ||
| From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes | Q44335899 | ||
| The influence of drug polarity on the absorption of opioid drugs into CSF and subsequent cephalad migration following lumbar epidural administration: application to morphine and pethidine | Q44350102 | ||
| European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe | Q44410690 | ||
| Optical control of antibacterial activity | Q45080632 | ||
| Photomodulation of conformational states. IV. Integrin-binding RGD-peptides with (4-aminomethyl)phenylazobenzoic acid as backbone constituent. | Q45215177 | ||
| Spacer-based selectivity in the binding of "two-prong" ligands to recombinant human carbonic anhydrase I. | Q45286870 | ||
| Robust visible light photoswitching with ortho-thiol substituted azobenzenes | Q45741218 | ||
| UV induced bystander signaling leading to apoptosis | Q46492734 | ||
| Improved photocontrol of alpha-chymotrypsin activity: peptidomimetic trifluoromethylketone photoswitch enzyme inhibitors | Q46502052 | ||
| A photoswitchable ITAM peptidomimetic: synthesis and real time surface plasmon resonance (SPR) analysis of the effects of cis-trans isomerization on binding. | Q46892586 | ||
| o-Fluoroazobenzenes as readily synthesized photoswitches offering nearly quantitative two-way isomerization with visible light | Q50238656 | ||
| Azobenzene photoswitching without ultraviolet light. | Q50266173 | ||
| Photoswitching azo compounds in vivo with red light. | Q50489942 | ||
| The synthetic food colouring agent Allura Red AC (E129) is not genotoxic in a flow cytometry-based micronucleus assay in vivo. | Q50489982 | ||
| Bidirectional photocontrol of peptide conformation with a bridged azobenzene derivative. | Q50496144 | ||
| Abc amino acids: design, synthesis, and properties of new photoelastic amino acids. | Q53587394 | ||
| Development of first photoresponsive prodrug of paclitaxel. | Q53614877 | ||
| Method of the Year 2010 | Q53996931 | ||
| Optogenetics | Q53996941 | ||
| Classical Chemotherapy: Mechanisms, Toxicities and the Therapeutc Window | Q56041025 | ||
| A Photochromic Agonist of AMPA Receptors | Q59888853 | ||
| Molecular Switches | Q63982149 | ||
| Glutathione. 13. Mechanism of thiol oxidation by diazenedicarboxylic acid derivatives | Q67444791 | ||
| Synthesis and structure-activity relations of disodium cromoglycate and some related compounds | Q69373934 | ||
| Photodynamic therapy in dermatology | Q71333691 | ||
| Photomodulation of conformational states. Synthesis of cyclic peptides with backbone-azobenzene moieties | Q73247952 | ||
| UV-induced apoptosis in resistant HeLa cells | Q74244505 | ||
| Corneal innervation and sensitivity to noxious stimuli in trkA knockout mice | Q77348458 | ||
| Diarylethenes for Memories and Switches | Q77451042 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Photopharmacology | Q30314060 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 2178-2191 | |
| P577 | publication date | 2014-02-04 | |
| P1433 | published in | Journal of the American Chemical Society | Q898902 |
| P1476 | title | Photopharmacology: Beyond Proof of Principle | |
| P478 | volume | 136 |
| Q90298943 | 796 nm Activation of a Photocleavable Ruthenium(II) Complex Conjugated to an Upconverting Nanoparticle through Two Phosphonate Groups |
| Q48136609 | A Photoswitchable Dualsteric Ligand Controlling Receptor Efficacy. |
| Q91739365 | A combinatorial approach to improving the performance of azoarene photoswitches |
| Q92742449 | A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery |
| Q52981912 | A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control. |
| Q90609577 | A photochromic upconversion nanoarchitecture: towards activatable bioimaging and dual NIR light-programmed singlet oxygen generation |
| Q50216822 | A red-shifted photochromic sulfonylurea for the remote control of pancreatic beta cell function. |
| Q39867491 | Acetylcholinesterase inhibitors with photoswitchable inhibition of β-amyloid aggregation |
| Q92108590 | Activation of sirtuin 2 inhibitors employing photoswitchable geometry and aqueous solubility |
| Q46237675 | Activation volumes for cis-to-trans isomerisation reactions of azophenols: a clear mechanistic indicator? |
| Q41143099 | Allosteric Optical Control of a Class B G-Protein-Coupled Receptor. |
| Q46584288 | An acido- and photochromic molecular device that mimics triode action |
| Q26783064 | Artificial Molecular Machines |
| Q42317190 | Arylazoindazole Photoswitches: Facile Synthesis and Functionalization via SNAr Substitution |
| Q91356195 | Axitinib: A Photoswitchable Approved Tyrosine Kinase Inhibitor |
| Q38673284 | Azo-Based Fluorogenic Probes for Biosensing and Bioimaging: Recent Advances and Upcoming Challenges |
| Q36120061 | Azobenzene Modified Imidacloprid Derivatives as Photoswitchable Insecticides: Steering Molecular Activity in a Controllable Manner |
| Q51562229 | Azobenzene photocontrol of peptides and proteins. |
| Q53389687 | Azobenzene-benzoylphenylureas as photoswitchable chitin synthesis inhibitors. |
| Q38755315 | BODIPY-Appended 2-(2-Pyridyl)benzimidazole Platinum(II) Catecholates for Mitochondria-Targeted Photocytotoxicity |
| Q39102443 | Bidirectional Photomodulation of Surface Tension in Langmuir Films |
| Q107159071 | Binding and Beyond: What Else Can G-Quadruplex Ligands Do? |
| Q105103928 | Chemical Z − E Isomer Switching of Arylazopyrazoles Using Acid |
| Q64896586 | Chemiluminescence-initiated and in situ-enhanced photoisomerization for tissue-depth-independent photo-controlled drug release. |
| Q58860053 | Chromo-pharmacophores: photochromic diarylmaleimide inhibitors for sirtuins |
| Q40907710 | Ciprofloxacin-Photoswitch Conjugates: A Facile Strategy for Photopharmacology |
| Q92704134 | Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review |
| Q90620500 | Computational Design and Synthesis of a Deeply Red-Shifted and Bistable Azobenzene |
| Q48330962 | Connectivity pattern modifies excited state relaxation dynamics of fluorophore-photoswitch molecular dyads |
| Q41042647 | Controlled drug release to cancer cells from modular one-photon visible light-responsive micellar system |
| Q42365675 | Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia |
| Q96586900 | Controlling PROTACs With Light |
| Q90059243 | Controlling the Circadian Clock with High Temporal Resolution through Photodosing |
| Q54267401 | Controlling the activity of quorum sensing autoinducers with light. |
| Q88509442 | Coumarin-diene photoswitches for rapid and efficient isomerization with visible light |
| Q48987033 | Design and synthesis of reversible solid-state photochromic pyrazolones by introducing a pyridine ring |
| Q40343223 | Design, Synthesis and Inhibitory Activity of Photoswitchable RET Kinase Inhibitors |
| Q55056451 | Design, Synthesis, and Characterization of a Photoactivatable Caged Prodrug of Imatinib. |
| Q91739448 | Design, synthesis and investigation of water-soluble hemi-indigo photoswitches for bioapplications |
| Q59654945 | Designing dynamic functional molecular systems |
| Q30582495 | Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine |
| Q57909567 | Dialkylated Dihydroazulene and Vinylheptafulvene Derivatives - Synthesis and Switching Properties |
| Q92745995 | Diastereoselective Synthesis and Two-Step Photocleavage of Ruthenium Polypyridyl Complexes Bearing a Bis(thioether) Ligand |
| Q41688421 | Dicyanomethylene Substituted Benzothiazole Squaraines: The Efficiency of Photodynamic Therapy In Vitro and In Vivo |
| Q90448265 | Diminished viability of human ovarian cancer cells by antigen-specific delivery of carbon monoxide with a family of photoactivatable antibody-photoCORM conjugates |
| Q46571666 | Direct Photocontrol of Peptidomimetics: An Alternative to Oxygen-Dependent Photodynamic Cancer Therapy |
| Q38817957 | Direct and Versatile Synthesis of Red-Shifted Azobenzenes |
| Q55424239 | Direct evidence for hula twist and single-bond rotation photoproducts. |
| Q48110939 | Efficient Sensitized Z→E Photoisomerization of an Iridium(III)-Azobenzene Complex over a Wide Concentration Range. |
| Q38845495 | Emerging Targets in Photopharmacology. |
| Q50697168 | Excited-state E → Z photoisomerization mechanism unveiled by ab initio nonadiabatic molecular dynamics simulation for hemithioindigo-hemistilbene. |
| Q57642164 | Exploring the diethylaminoflavylium derivatives multistate system of chemical reactions in the presence of CTAB micelles: thermodynamic reversibility achieved through different kinetic pathways |
| Q57909560 | Functionalization and Properties of Tetrahydronaphtho[2,1-a ]azulene Photoswitches |
| Q96647271 | Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes |
| Q52867184 | Gating the photochromism of an azobenzene by strong host-guest interactions in a divalent pseudo[2]rotaxane. |
| Q98623649 | Green light triggered [2+2] cycloaddition of halochromic styrylquinoxaline-controlling photoreactivity by pH |
| Q63888837 | Green light-induced apoptosis in cancer cells by a tetrapyridyl ruthenium prodrug offering two coordination sites |
| Q48166849 | Green-Light-Sensitive BODIPY Photoprotecting Groups for Amines |
| Q48271099 | High-Precision Photothermal Ablation Using Biocompatible Palladium Nanoparticles and Laser Scanning Microscopy |
| Q52941655 | Hydrazone switches and things in between. |
| Q112569443 | Hypothesis-Driven, Structure-Based Design in Photopharmacology: The Case of eDHFR Inhibitors |
| Q42327808 | Illuminating Phenylazopyridines To Photoswitch Metabotropic Glutamate Receptors: From the Flask to the Animals |
| Q64981220 | Iminothioindoxyl as a molecular photoswitch with 100 nm band separation in the visible range. |
| Q48122048 | Internal Targeting and External Control: Phototriggered Targeting in Nanomedicine. |
| Q48173413 | Isomerisation of an intramolecular hydrogen-bonded photoswitch: protonated azobis(2-imidazole). |
| Q41029112 | Light-Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy |
| Q48049713 | Light-Controlled Reversible Modulation of Frontier Molecular Orbital Energy Levels in Trifluoromethylated Diarylethenes. |
| Q90976744 | Light-Switchable Antagonists for the Histamine H1 Receptor at the Isolated Guinea Pig Ileum |
| Q38704077 | Light-Switchable Peptides with a Hemithioindigo Unit: Peptide Design, Photochromism, and Optical Spectroscopy |
| Q92898686 | Light-controllable dithienylethene-modified cyclic peptides: photoswitching the in vivo toxicity in zebrafish embryos |
| Q38634892 | Light-induced regulation of ligand-gated channel activity. |
| Q55413992 | London dispersion as important factor for the stabilization of (Z)-azobenzenes in the presence of hydrogen bonding. |
| Q64096540 | Mapping the Azolog Space Enables the Optical Control of New Biological Targets |
| Q93200020 | Membrane Environment Enables Ultrafast Isomerization of Amphiphilic Azobenzene |
| Q55407405 | Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules. |
| Q58717799 | Molecular Motors in Aqueous Environment |
| Q42754840 | N-alkynyl derivatives of 5-fluorouracil: susceptibility to palladium-mediated dealkylation and toxigenicity in cancer cell culture |
| Q92471894 | NIR-Light-Driven Generation of Reactive Oxygen Species Using Ru(II)-Decorated Lipid-Encapsulated Upconverting Nanoparticles |
| Q93116271 | NIR-light-mediated spatially selective triggering of anti-tumor immunity via upconversion nanoparticle-based immunodevices |
| Q64965156 | New molecular switch architectures. |
| Q92854788 | Noncovalent Interactions with Proteins Modify the Physicochemical Properties of a Molecular Switch |
| Q58799345 | Optical Control of Antimicrobial Activity in Quinolone Derivatives |
| Q38818301 | Optical Control of Insulin Secretion Using an Incretin Switch. |
| Q42315229 | Optical control of AMPA receptors using a photoswitchable quinoxaline-2,3-dione antagonist |
| Q50213869 | Optical control of GIRK channels using visible light |
| Q36408637 | Optical control of a receptor-linked guanylyl cyclase using a photoswitchable peptidic hormone |
| Q34397447 | Optical control of insulin release using a photoswitchable sulfonylurea |
| Q37585109 | Optical control of neuronal activity using a light-operated GIRK channel opener (LOGO). |
| Q90448226 | Optical control of the nuclear bile acid receptor FXR with a photohormone |
| Q64074239 | Optoelectronic control of single cells using organic photocapacitors |
| Q90167761 | Optofluidic control of rodent learning using cloaked caged glutamate |
| Q54284866 | Orthogonal control of antibacterial activity with light. |
| Q42419016 | Orthogonal photoswitching in a multifunctional molecular system |
| Q30629552 | Palladium-mediated dealkylation of N-propargyl-floxuridine as a bioorthogonal oxygen-independent prodrug strategy |
| Q49186644 | Perspective: Opportunities for ultrafast science at SwissFEL. |
| Q57629101 | Photo-Triggered Microcapsules |
| Q41191944 | Photo-enhanced Aqueous Solubilization of an Azo-compound |
| Q88002159 | Photochemical Control of Protein Arginine Deiminase (PAD) Activity |
| Q38294559 | Photochemical Regulation of Gene Expression Using Caged siRNAs with Single Terminal Vitamin E Modification. |
| Q48223347 | Photochromic Dopamine Receptor Ligands Based on Dithienylethenes and Fulgides |
| Q41849201 | Photochromic benzo[b]phosphole oxide with excellent thermal irreversibility and fatigue resistance in the thin film solid state via direct attachment of dithienyl units to the weakly aromatic heterocycle |
| Q42278649 | Photochromic coenzyme Q derivatives: switching redox potentials with light. |
| Q53272199 | Photochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides. |
| Q47128488 | Photocontrol of Antibacterial Activity: Shifting from UV to Red Light Activation. |
| Q52656541 | Photocontrol of ion permeation in lipid vesicles with amphiphilic dithienylethenes. |
| Q42366734 | Photoisomerization of Arylazopyrazole Photoswitches: Stereospecific Excited-State Relaxation |
| Q53084237 | Photoisomerization of azobenzenes isolated in cryogenic matrices. |
| Q41888043 | Photomodulation of bacterial growth and biofilm formation using carbohydrate-based surfactants |
| Q42375087 | Photopharmacology |
| Q64089491 | Photoregulated fluxional fluorophores for live-cell super-resolution microscopy with no apparent photobleaching |
| Q52869988 | Photoreversible prodrugs and protags: switching the release of maleimides by using light under physiological conditions. |
| Q48376451 | Photoswitchable Intramolecular Hydrogen Bonds in 5-Phenylazopyrimidines Revealed By In Situ Irradiation NMR Spectroscopy |
| Q48055013 | Photoswitchable NIR-Emitting Gold Nanoparticles |
| Q36378377 | Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog. |
| Q42089811 | Photoswitchable fatty acids enable optical control of TRPV1. |
| Q50250892 | Photoswitchable molecules as key ingredients to drive systems away from the global thermodynamic minimum. |
| Q35801367 | Photoswitching the mechanical properties in Langmuir layers of semifluorinated alkyl-azobenzenes at the air-water interface |
| Q35541515 | Phototriggerable peptidomimetics for the inhibition of Mycobacterium tuberculosis ribonucleotide reductase by targeting protein-protein binding |
| Q38791247 | Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation |
| Q90694693 | Polymeric Photoacids Based on Naphthols-Design Criteria, Photostability, and Light-Mediated Release |
| Q51062991 | Proteasome inhibitors with photocontrolled activity. |
| Q30382639 | Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase |
| Q38765131 | Recent developments in reversible photoregulation of oligonucleotide structure and function |
| Q50440489 | Red, far-red, and near infrared photoswitches based on azonium ions |
| Q41037080 | Redox Control over Acyl Hydrazone Photoswitches. |
| Q33670713 | Remote control of glucose homeostasis in vivo using photopharmacology |
| Q64868285 | Remote control of movement disorders using a photoactive adenosine A2A receptor antagonist |
| Q50866124 | Remote control over folding by light. |
| Q47162713 | Remote light-controlled intracellular target recognition by photochromic fluorescent glycoprobes. |
| Q36489395 | Restoring Light Sensitivity in Blind Retinae Using a Photochromic AMPA Receptor Agonist |
| Q93008411 | Reversible Photocontrolled Nanopore Assembly |
| Q48325255 | Reversible optical control of F1 Fo -ATP synthase using photoswitchable inhibitors. |
| Q99579659 | Reversible photo-control over transmembrane anion transport using visible-light responsive supramolecular carriers |
| Q89821201 | Reversible photoswitching of the DNA-binding properties of styrylquinolizinium derivatives through photochromic [2 + 2] cycloaddition and cycloreversion |
| Q92732186 | Reversible silencing of endogenous receptors in intact brain tissue using 2-photon pharmacology |
| Q37581385 | Reversibly extracellular pH controlled cellular uptake and photothermal therapy by PEGylated mixed-charge gold nanostars |
| Q41823674 | Sequential Uncaging with Green Light can be Achieved by Fine-Tuning the Structure of a Dicyanocoumarin Chromophore. |
| Q47373586 | Shedding light on photo-switchable analgesics for pain |
| Q96586959 | Short Photoswitchable Antibacterial Peptides |
| Q52321849 | Simultaneous complementary photoswitching of hemithioindigo tweezers for dynamic guest relocalization. |
| Q59458216 | Solvent Effects on the Actinic Step of Donor-Acceptor Stenhouse Adduct Photoswitching |
| Q59458228 | Solvent Effects on the Actinic Step of Donor-Acceptor Stenhouse Adduct Photoswitching |
| Q55232052 | Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology. |
| Q34431490 | Synthesis and antibacterial activities of antibacterial peptides with a spiropyran fluorescence probe |
| Q90118189 | Synthesis of 5-Alkyl- and 5-Phenylamino-Substituted Azothiazole Dyes with Solvatochromic and DNA-Binding Properties |
| Q91643716 | Synthesis of Functionalized Azobiphenyl- and Azoterphenyl- Ditopic Linkers: Modular Building Blocks for Photoresponsive Smart Materials |
| Q59327175 | Synthesis of mono-functionalized S-diazocines via intramolecular Baeyer–Mills reactions |
| Q48350906 | Tailoring Photoisomerization Pathways in Donor-Acceptor Stenhouse Adducts: The Role of the Hydroxy Group. |
| Q48112136 | Taking Photochromism beyond Visible: Direct One-Photon NIR Photoswitches Operating in the Biological Window. |
| Q64059829 | Taming the Complexity of Donor-Acceptor Stenhouse Adducts: Infrared Motion Pictures of the Complete Switching Pathway |
| Q53450183 | The (photo)chemistry of Stenhouse photoswitches: guiding principles and system design. |
| Q38556805 | The Art of Building Small: From Molecular Switches to Motors (Nobel Lecture). |
| Q39669025 | The Quest for Photoswitches Activated by Near-Infrared Light: A Theoretical Study of the Photochemistry of BF2 -Coordinated Azo Derivatives. |
| Q46662167 | The cis-Diammineplatinum(II) Complex of Curcumin: A Dual Action DNA Crosslinking and Photochemotherapeutic Agent |
| Q52874248 | The effect of photoisomerization on the enzymatic hydrolysis of polymeric micelles bearing photo-responsive azobenzene groups at their cores. |
| Q42734836 | The role of alkyl substituents in deazaadenine-based diarylethene photoswitches |
| Q55216417 | The role of beta cell heterogeneity in islet function and insulin release. |
| Q63982072 | Transition metal functionalized photo- and redox-switchable diarylethene based molecular switches |
| Q48095319 | Tuning the Effects of Bacterial Membrane Permeability through Photo-Isomerization of Antimicrobial Cationic Amphiphiles. |
| Q46017441 | Understanding and improving photo-control of ion channels in nociceptors with azobenzene photo-switches. |
| Q89738073 | Unidirectional rotating molecular motors dynamically interact with adsorbed proteins to direct the fate of mesenchymal stem cells |
| Q53736693 | Unraveling the Photoswitching Mechanism in Donor-Acceptor Stenhouse Adducts. |
| Q91619298 | Unveiling how intramolecular stacking modes of covalently linked dimers dictate photoswitching properties |
| Q90334650 | Visible-Light Controlled Release of a Fluoroquinolone Antibiotic for Antimicrobial Photopharmacology |
| Q42315016 | Visible-Light Excitation of a Molecular Motor with an Extended Aromatic Core. |
| Q48050086 | Visible-Light-Triggered Activation of a Protein Kinase Inhibitor |
| Q23923928 | Visible-light-triggered molecular photoswitch based on reversible E/Z isomerization of a 1,2-dicyanoethene derivative |
| Q38445566 | Wavelength-selective cleavage of photoprotecting groups: strategies and applications in dynamic systems |
| Q50047035 | pH-sensitive Compounds for Selective Inhibition of Acid-producing Bacteria. |
Search more.